Search

Your search keyword '"Foscarnet -- Evaluation"' showing total 3 results
Start Over Descriptor "Foscarnet -- Evaluation" Publisher lippincott williams & wilkins, wk health
3 results on '"Foscarnet -- Evaluation"'

1. Treatment of mucocutaneous herpes simplex virus infections unresponsive to acyclovir with topical foscarnet cream in AIDS patients: a phase I/II study

Author

Javaly, Kedarnath, Wohlfeiler, Michael, Kalayjian, Robert, Klein, Thomas, Bryson, Yvonne, Grafford, Kerstin, Martin-Munley, Sarah, and Hardy, W. David

Subjects
Foscarnet -- Evaluation, Herpes simplex virus, Skin lesions, Acyclovir -- Evaluation, Health
Abstract

The authors tested foscarnet 1% cream on AIDS patients who had herpes simplex lesions on mucoid surfaces which had not responded to treatment with acyclovir. The foscarnet cream seemed safe and effective.

Published
1999

2. Effect of antiviral drugs used to treat cytomegalovirus end-organ disease on subsequent course of previously diagnosed Kaposi's sarcoma in patients with AIDS

Author

Robles, Robert, Lugo, Denise, Gee, Lauren, and Jacobson, Mark A.

Subjects
Kaposi's sarcoma -- Development and progression, Foscarnet -- Evaluation, AIDS patients -- Diseases, Health
Abstract

Foscarnet may be effective in preventing the progression of Kaposi's sarcoma (KS). KS is a skin tumor that occurs often in HIV patients. Researchers analyzed the progression of KS in 66 patients who were taking foscarnet or ganciclovir to treat cytomegalovirus infection. All of the patients also had a history of KS. In the patients taking foscarnet, it took an average of 211 days for a new tumor to develop or for an existing one to get bigger. In the patients taking ganciclovir, it took an average of 22 days.

Published
1999

Catalog

Books, media, physical & digital resources
See catalog results